Changes

361 bytes added ,  19:31, September 25, 2022
no edit summary
Line 23: Line 23:  
"even the FDA has acknowledged that off-label use of a drug may be appropriate and rational (see Use of Approved Drugs for Unlabeled Indicators, FDA Drug Bulletin (Public Health Service, Md.) April 1982, vol. 12, No. 1, 4-5)."  
 
"even the FDA has acknowledged that off-label use of a drug may be appropriate and rational (see Use of Approved Drugs for Unlabeled Indicators, FDA Drug Bulletin (Public Health Service, Md.) April 1982, vol. 12, No. 1, 4-5)."  
 
''Proctor v. Davis'', 291 Ill. App. 3d 265, 295, 225 Ill. Dec. 126, 146, 682 N.E.2d 1203, 1223 (1997) (dissent).
 
''Proctor v. Davis'', 291 Ill. App. 3d 265, 295, 225 Ill. Dec. 126, 146, 682 N.E.2d 1203, 1223 (1997) (dissent).
 +
 +
== See also ==
 +
Steven R. Salbu, Off-Label Use, Prescription, and Marketing of FDA-Approved Drugs: An Assessment of Legislative and Regulatory Policy, 51 FLA. L. REV. 181, 189-92 (1999); ''see Chaney v. Heckler'', 231 U.S. App. D.C. 136, 718 F.2d 1174, 1180 (D.C. Cir. 1983), ''rev'd on other grounds'', 470 U.S. 821, 105 S. Ct. 1649, 84 L. Ed. 2d 714 (1985).
 +
 
== References ==
 
== References ==
 
{{reflist}}
 
{{reflist}}
 
[[Category:Drugs]]
 
[[Category:Drugs]]
Anthony, Irenaeus, Siteadmin, apieditor, Bureaucrats, Check users, nsAm_Govt_101RO, nsAm_Govt_101RW, nsAm_Govt_101_ta, nsJudgesRO, nsJudgesRW, nsJudges_talkRO, nsJudges_talkRW, nsTeam2RO, nsTeam2RW, nsTeam2_talkRO, nsTeam2_talkRW, oversight, Administrators
126,215

edits